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Early steps of retroviral replication involve reverse transcription of the viral RNA genome and integration of the resulting
cDNA copy into a chromosome of the host cell. The initial DNA breaking and joining steps of integration are carried out by
the virus-encoded integrase enzyme. Integrases bind specifically to the ends of the unintegrated viral cDNA but nonspe-
cifically to target DNA. Conventional assays in vitro reveal primarily the nonspecific DNA binding mode, complicating studies
of integrase–DNA complexes. Here, we report an investigation of unconventional DNA structures useful for positioning
integrase at predetermined sites. We find that paired DNA three-way junctions can be used to mimic branched DNAs
normally formed as reaction intermediates. The three-way junctions differ from authentic intermediates in the connectivity
of the DNAs, which, in contrast to the authentic intermediate, allow formation of stable DNA structures under physiological
conditions. Assays in vitro showed that integrase can direct hydrolysis at sequences resembling the viral cDNA ends within
the three-way junction, but not on junctions with mutant sequences. Changing the spacing between the paired three-way
junctions disrupted the cleavage pattern, emphasizing the importance of the correct DNA scaffold. DNase I footprinting
studies revealed protection of specific bases at the terminus of the LTR in the three-way junction complex, but not on control
linear DNA, specifying the locations of tight interactions between integrase and DNA. Paired DNA three-way junctions are
attractive reagents for structural studies of integrase–DNA complexes. © 2001 Academic Press
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1INTRODUCTION
A critical step in the replication of a retrovirus is the
integration of the viral genome into the host DNA. This
function is carried out by the virus-encoded integrase
enzyme (for reviews, see Brown, 1997; Esposito and
Craigie, 1999; Hansen et al., 1998). Integration has been
the focus of intense study partly as a model of enzymatic
DNA breakage and joining reactions, and partly because
it is the only enzyme encoded by the human immunode-
ficiency virus (HIV) for which there are not yet clinically
useful inhibitors (Bushman et al., 1998; Hansen et al.,
1998; Hazuda et al., 2000; Mathe, 2000; Pommier and
Neamati, 1999; Thomas and Brady, 1997). In this study,
we have chosen to examine the integrase of Rous sar-
coma virus (RSV), which is relatively soluble compared to
many integrases and for which a structure of a dimer
containing two of the three protein domains has recently
become available (Bujacz et al., 1995; Yang et al., 2000).
Upon entry into the cell, the retroviral RNA genome is
reverse transcribed to generate a double-stranded linear
cDNA copy of the viral RNA genome. Each end of the
linear viral cDNA contains a long terminal repeat se-
quence (LTR), which is composed of U3, R, and U5
regions. In vivo, integrase enzyme assembles onto the
LTR cDNA, along with several other proteins, to form the
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304preintegration complex (PIC) (Brown, 1997; Hansen et al.,
1998).
Integration begins with removal of a short oligonucle-
otide from each 39 end of the viral cDNA, a dinucleotide
in the RSV case, leaving a two-base 59 overhang (Fig.
A). The recessed 39 ends are then joined to 59 ends in
he target DNA (strand transfer reaction; Fig. 1B) (Brown
t al., 1989; Fujiwara and Mizuuchi, 1988). Purified inte-
rase protein can carry out the terminal cleavage and
trand transfer reactions in vitro (Bushman et al., 1990;
raigie et al., 1990; Katz et al., 1990; Katzman et al., 1989;
herman and Fyfe, 1990). Insertion of the DNA ends
ccurs on either side of a DNA major groove (Pruss et al.,
994; Pryciak et al., 1992). The gaps resulting from inte-
ration are likely to be repaired by host DNA repair
nzymes (Yoder and Bushman, 2000). This leaves a char-
cteristic 6-bp duplication on either end of the inserted
rovirus for RSV, while for HIV the duplication is 5 bp.
arget site selection appears to be only loosely se-
uence-dependent (Bor et al., 1996; Carteau et al., 1998;
itzgerald and Grandgenett, 1994; Pryciak et al., 1992a,b;
ryciak and Varmus, 1992). However, integration is fa-
ored in vitro at sites of DNA distortion, often associated
ith curvature of the target DNA (Bor et al., 1995; Pruss
t al., 1994; Pryciak et al., 1992a,b; Pryciak and Varmus,
992).
The integrase molecule is composed of three protein
omains. The amino-terminal domain binds zinc, the
entral domain contains the active site, and the carboxyl-
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305DNA SCAFFOLDS FOR INTEGRASE COMPLEX ASSEMBLYterminal domain contributes to DNA binding (Bujacz et
l., 1995; Cai et al., 1997; Dyda et al., 1994; Eijkelenboom
t al., 1997; Yang and Steitz, 1995). Each of the three
omains has been shown to dimerize, and the full-length
rotein has been shown to function as a multimer (Ei-
kelenboom et al., 1995; Engelman et al., 1993; Lodi et al.,
995; van Gent et al., 1993). Recent structures of two
omain integrase derivatives, containing the catalytic
nd C-domains of RSV, SIV, and HIV, provide further
vidence for dimerization and allow higher order com-
lexes to be modeled (Chen et al., 2000a,b; Yang et al.,
000).
While catalysis is dependent on the sequences at the
nds of the viral cDNA, retroviral integrase binds DNA
argely nonspecifically, showing at most slight prefer-
nce for binding to the LTR ends in vitro (Engelman et al.,
994; Hazuda et al., 1994; Pemburton et al., 1996;
chauer and Billich, 1992; van Gent et al., 1991; Vink and
lasterk, 1993; Woerner et al., 1992; Yi et al., 1999; Yoshi-
aga et al., 1994). Integrase likely has multiple DNA
inding modes, a specific mode for binding the LTR ends
nd a nonspecific binding mode for capturing target
NA. This has complicated efforts to study DNA–inte-
rase complexes, since nonspecific binding obstructs
fforts to analyze specific complexes.
In an effort to constrain the position of integrase on
NA, we have developed branched substrate molecules
esigned to form scaffolds that restrict integrase binding.
FIG. 1. Integration of cDNA by Rous sarcoma virus integrase. The 59
ends of the DNA strands are represented by spheres. After assembly
of the viral cDNA and the integrase protein into the preintegration
complex, integrase removes a dinucleotide from the 39 end of each end
of the viral cDNA (A). The modified preintegration complex then binds
to the host target DNA. A strand transfer reaction then takes place in
which the 39 ends of the viral cDNA are joined to the target DNA,
simultaneously producing a nick in the target strand (B).igure 2A illustrates the DNA junction expected in an
ntegration intermediate. The upper and lower arms
T
codel the viral cDNA ends, while the other two arms
odel target DNA. Several groups have studied the ac-
ion of HIV integrase on such substrates (named “cross-
one disintegration” substrates) (Chow and Brown,
994b; Mazumder et al., 1994; van den Ent et al., 1994).
he two halves of the substrate are joined by only the 5
arget base pairs between the LTR arms, forming the
rossbone structure. The 5-bp target region is not ex-
ected to be stably base paired under physiological or
xperimental conditions, so in solution the crossbone
ubstrate will be present as two halves. Integrase was
ound nevertheless to carry out reactions in which a 39
nd in one half attacked DNA sites in the other, indicat-
FIG. 2. Artificial integration intermediates. The two viral ends are joined
to different target strands, but on the same side of the double helix, across
the major groove. For RSV integrase, integrated viral strands are separated
by 6 bases of host DNA. 59 DNA strand ends are represented by a filled
ircle. (A) Artificial integration intermediate modeling integrase reaction
roduct. (B) Paired three-way junction modeling an integration product.
he 59 overhanging dinucleotide is joined to the 39 end of the adjacent
arget strand. (C) Paired three-way junction, 3H2S-6L-3H2S, modeling the
ntegration intermediate. The light gray boxes indicate RSV LTR sequence.
he dark gray boxes indicate restriction enzyme cleavage sites for use in
haracterizing the substrate.
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306 JOHNSON AND BUSHMANing that integrase protein–protein interactions can ap-
pose the two halves of this substrate to permit covalent
chemistry.
In this study, we have constructed related DNA struc-
tures that are stable in the absence of integrase, with the
goal of using such molecules to direct integrase binding
to specific locations. To form stable DNA scaffolds, the 59
overhanging nucleotides are joined to the 39 ends of the
arget arms, forming a pair of three-way DNA junctions
Fig. 2B). We find that integrase binds specifically to
orrect three-way junction substrates and carries out
ydrolysis at the junction between the viral cDNA and
arget DNA, allowing us to study the integrase–DNA
omplexes formed.
RESULTS
esign and nomenclature of paired DNA three-way
unctions
We have constructed branched DNA molecules, dou-
le three-way junctions, in which two arms model the
iral cDNA ends, and the other two model target DNA
Fig. 2B, sequence presented in Fig. 2C). The junction
oints are separated by 6 bp, the normal spacing in the
arget DNA between the points of joining of the RSV
DNA ends. In our model DNAs, the three-way junctions
re formed (conceptually) by joining the 59 overhanging
inucleotide in the viral DNA end to the 39 end of the
djacent target strand. This has the advantage of stabi-
izing the fully base-paired DNA in solution, though we
ote it has the potential to distort the substrate out of the
ptimal conformation for binding or catalysis by inte-
rase. We first discuss construction and assay of these
ubstrates and then studies probing the optimal confor-
ation.
We have devised a nomenclature for double three-way
unction molecules that extends the naming system used
reviously for single three-way junctions (Welch et al.,
995). The double three-way junction shown in Fig. 2C is
ermed 3H2S-6L-3H2S. “3H” refers to the three helices in
junction, and “2S” refers to the two-base single-
tranded bulge as in Welch et al. (1995). The “6L” refers
o the 6-bp linker between three-way junctions.
The 3H2S-6L-3H2S sequence includes 13 bp of the
SV-LTR on each of the two LTR arms, one matching
he U5 LTR sequence, and the other matching U3 LTR
equence, as expected for the RSV integration inter-
ediate (Katz et al., 1982) (Fig. 2C). The sequence
etween the LTR arms was chosen to match the weak
onsensus derived from studies of avian integrase
arget sites (Fitzgerald and Grandgenett, 1994). Se-
uences at the tips of the four DNA arms containestriction enzyme recognition sites for analysis of
NA duplex formation.
c
cssaying the conformation of 3H2S-6L-3H2S
The four DNA strands comprising 3H2S-6L-3H2S were
ynthesized as oligonucleotides and annealed by heat-
ng to 95°C and slow cooling to 4°C. A crucial point for
urther studies was that of whether the resulting prod-
cts were homogenous double three-way junctions or
eterogeneous partially single-stranded forms. Annealed
NA products were analyzed on native polyacrylamide
els and found to yield single predominant labeled
ands (Fig. 3A), consistent with correct assembly. To test
he extent of annealing more rigorously, the 3H2S-6L-
H2S substrate was end-labeled on each of the two
arget DNA arms and probed by cleavage with restriction
nzymes (Figs. 3B and 3C). After cleavage, samples were
enatured and separated by electrophoresis on DNA
equencing-type gels. For this experiment, the left target
rm is one base shorter than the right target arm, allow-
ng analysis of each in the same reaction mixture. The
ncut sample yielded two closely spaced bands corre-
ponding to the two labeled strands (compare Fig. 3C,
anes 1 and 2 with 3). Cleavage with restriction enzymes
hat cut in each of the four DNA arms yielded nearly
omplete digestion, indicative of correct duplex forma-
ion (Fig. 3C, lanes 4–7). Control experiments showed
hat the restriction enzymes used only cleave double-
tranded DNA efficiently and not single-stranded DNA
data not shown). These studies indicated that the an-
ealing procedure resulted in efficient assembly of each
rm in the three-way junction.
These data do not address the conformation of the
NA at the three-way junction, which may well contain
ne or several melted base pairs. In addition, possible
ase pairing of the six complementary bases in the linker
egion was not directly assayed, and these bases may
ell not be stably base paired (discussed below). A
urther unknown is the DNA stacking interactions at the
hree-way junction, which will dictate the directions in
hich the DNA arms project from the junction region.
ntegrase is known to distort its DNA substrates upon
inding, and DNA distortion in model substrates pro-
otes catalysis by integrase. We therefore expect that
he binding of integrase will result in local unpairing and
otentially other types of DNA distortion at the three-way
unction, so that effects of added integrase will largely
ictate the DNA conformation.
ntegrase-catalyzed hydrolysis on 3H2S-6L-3H2S
Integrase-catalyzed hydrolysis was tested as a first
tep in characterizing the integrase–DNA complexes
ormed on the paired three-way junctions. The 3H2S-6L-
H2S substrate was 59 labeled on the U5 LTR end and
ncubated with RSV integrase. The reactivity of 3H2S-6L-
H2S was first compared to the previously reported
rossbone integration substrate (Fig. 4A). The extent of
leavage, as measured by the release of the labeled LTR
R
a
w
c
o
u
307DNA SCAFFOLDS FOR INTEGRASE COMPLEX ASSEMBLYfragment, was comparable between the two substrates
(about 7% cleavage). This supports the idea that inte-
FIG. 3. Characterization of 3H2S-6L-3H2S substrate. (A) The 3H2S-
6L-3H2S substrate was electrophoresed under nondenaturing condi-
tions (lane 1). Single-stranded EPJ41 is also shown for comparison
(lane 2). Diagrams of the substrate in each lane is shown above. (B) The
3H2S-6L-3H2S substrate used for restriction enzyme characterization.
Oligonucleotides EPJ42a and EPJ44 are indicated by arrows, and are 59
end labeled in this experiment. Positions of 32P labeling are indicated
by an asterisk. The positions of restriction enzyme cleavage sites are
indicated by open boxes. (C) The 3H2S-6L-3H2S substrate was undi-
gested (lane 3) or treated with EarI (lane 4), AciI (lane 5), BsrBI (lane 6),
or BssSI (lane 7). Labeled oligonucleotides EPJ42a and EPJ44 were
also loaded individually for comparison (lanes 1 and 2, respectively).
The running positions of EPJ42a and EPJ44 are marked with closed
circles. The minor band in lane 4 is likely due to the presence of 21
forms of the oligonucleotide. The minor band in lane 5 is probably a
partial digestion product. The BsrBI restriction site contains an AciI site
ithin it, so cleavage by AciI at this site coupled with inefficient
leavage at the AciI site on the right target arm will produce a fragment
f the length seen for the extra band in lane 5. All restriction enzymes
sed are inactive on single-stranded DNA substrates.grase is assembling on the 3H2S-6L-3H2S substrate
with an efficiency similar to the crossbone substrate.The activities in Mg21 and Mn21 were compared, since
SV integrase is known to be active in both (Bushman
nd Wang, 1994; Katz et al., 1990; Katzman et al., 1989). In
the presence of Mn21, a product was generated of the
size expected for integrase-mediated cleavage adjacent
to the conserved CA dinucleotide (Fig. 4B). This is the
site of hydrolysis by the normal terminal cleavage activity
of integrase, though, in this case, taking place in the DNA
three-way junction. Cleavage also occurred in the pres-
ence of Mg21, the metal cofactor expected to be em-
ployed in vivo, though to a lesser extent (Fig. 4B, lanes
6–8). In addition, hydrolysis was also carried out to a
similar extent by RSV IN 49–286 (summarized in Fig. 5).
The correct LTR sequence is required for integrase-
mediated hydrolysis
Several mutant versions of the 3H2S-6L-3H2S sub-
strate were constructed to probe the features necessary
for hydrolysis. Autoradiograms illustrating cleavage of
substrates 59 labeled on the U5 ends are shown in Fig. 4.
Data for cleavage at all points in the DNA substrates
(involving independent labeling of each DNA strand in
the substrate) are summarized in Fig. 5. A mutant version
of the substrate (mut3H2S-6L-3H2S) was constructed in
which the last 6 bases of each viral DNA strand were
replaced with nonspecific bases (Fig. 4C). This allows
the importance of the correct terminal LTR sequences to
be evaluated. No significant activity was seen, indicating
that the cleavage activity is strictly dependent on the
presence of the correct LTR sequence.
Correct spacing between three-way junctions is
required for optimal cleavage
Another mutant was also constructed, 3H2S-11L-
3H2S, in which 5 extra bases were added to the 6-bp
linker region (Fig. 4D). The separation of the viral arms by
a half-helical turn places them on opposite sides of the
target DNA helix, allowing the importance of spacing to
be assessed. Cleavage was observed in Mn21 at the
correct positions at the ends of the LTR DNA arms,
though at least threefold weaker at each position than
with the correct 3H2S-6L-3H2S cleavage. Additional ab-
normal cleavages were observed one turn downstream,
opposite the other LTR DNA arm. Evidently, the addition
of a half-helical turn between the two viral DNA ends
disrupted the cleavage reaction, reducing the efficiency
and leading to hydrolysis at ectopic sites. As a control, a
substrate with altered spacing and mutated LTR se-
quences was also constructed (mut3H2S-11L-3H2S;
Figs. 5G and 5H). For the mut3H2S-11L-3H2S substrate,
normal cleavage was abolished by the mutation of the
LTR DNA ends, but the aberrant downstream cleavage
persisted, indicating that downstream cleavage is not
dependent on the LTR sequence.
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308 JOHNSON AND BUSHMANOptimizing the ectopic connection between the LTR
59 end and the target DNA 39 end
Several substrates were assayed to optimize the ec-
topic connection between the LTR 59 end and the target
DNA 39 end at the paired three-way junction. The nature
of the ectopic connection between the viral cDNA 59 end
nd the target 39 end could have several effects on
ubstrate conformation, such as constraining rotation of
he LTR arm around its long axis relative to the target
NA part of the substrate or affecting stacking of the
NA arms at the junction. The bulge region, while nec-
FIG. 4. Junction cleavage of the crossbone substrate, 3H2S-6L-3H
integrase. Substrates were labeled on the U5 viral arm. (A) Compariso
The concentrations of integrase added are indicated above the lane
3H2S-6L-3H2S. (C) Cleavage of mut3H2S-6L-3H2S. (D) Cleavage of 3
substrate is shown adjacent to the panel. Reaction buffers contained M
or 0, 10, 20, and 30 min. The locations of LTR and target sequences for
ocations of the LTR, 11-bp linker, and target sequences for the 3H2S-ssary for stable assembly of the paired three-way junc-
ions, has the potential to interfere with integrase bindingto the LTR end. In the 3H-6L-3H substrate, the 2-base
bulge regions were removed (Figs. 4E, 5I,and 5J). The
3H-6L-3H three-way junction was cleaved with the same
efficiency and specificity as with 3H2S-6L-3H2S, despite
the removal of the 2-base bulge.
Substrates with 2-, 4-, or 6-base bulges were next
compared (Fig. 6). All were cleaved by both RSV IN
49–286 and RSV integrase in the presence of both Mn21
and Mg21. Cleavage efficiency increased with increasing
ulge length when treated with RSV integrase in the
resence of Mg21 (Fig. 6. lanes 6, 12, and 18). Evidently.
t3H2S-6L-3H2S, 3H2S-11L-3H2S, and 3H-6L-3H with full-length RSV
e cleavage of the crossbone substrate to cleavage of 3H2S-6L-3H2S.
actions were carried out for 30 min. (B) Time course of cleavage of
L-3H2S. (E) Cleavage of the 3H-6L-3H substrate. A diagram of each
nes 1–4) or Mg21 (lanes 5–8), and incubation was performed at 37°C
6L-3H2S, mut3H2S-6L-3H2S, and 3H2S-6L-3H2S are shown at left. The
2S substrate are also shown.2S, mu
n of th
. All re
H2S-11
n21 (la
3H2S-the longer bulge facilitated integrase-mediated hydroly-
sis.
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309DNA SCAFFOLDS FOR INTEGRASE COMPLEX ASSEMBLYAssays of a substrate lacking base pairing in the
linker region
FIG. 5. Summary of three-way junction cleavage data. (A and B)
leavage of 3H2S-6L-3H2S substrate. (C and D) Cleavage of mut3H2S-
L-3H2S. (E and F) Cleavage of 3H2S-11L-3H2S. (G and H) Cleavage of
he mut3H2S-11L-3H2S substrate. (I and J) Cleavage of 3H-6L-3H sub-
trate. Treatment by RSV IN 49–286 is shown in (A), (C), (E), (G) and (I).
reatment by full-length RSV integrase is shown in (B), (D), (F), (H) and
J). Cleavage of substrate is expressed in percent of substrate cleaved.
large filled triangle indicates a site at which .5% of the substrate is
cleaved in the presence of Mn21, a small filled triangle indicates 1–5%
cleavage in Mn21, and an open triangle indicates .0.2% cleavage in
g21.As mentioned above, it is unknown whether the linker
region in the 3H2S-6L-3H2S substrate is stably base wpaired, so, to probe this issue, a substrate incapable of
base pairing was constructed and tested. The substrate,
named 3H2S-6BL-3H2S for “bubbled linker,” was cleaved
with efficiency indistinguishable from the wild type (Fig.
7). Thus, integrase is equally capable of converting the
substrate to a conformation suitable for hydrolysis re-
gardless of whether or not the linker region is capable of
base pairing. Whether or not the linker region in 3H2S-
6L-3H2S is base paired normally is unknown.
DNase I footprint analysis of complexes
DNase I footprint experiments were performed to de-
termine whether RSV integrase binds specifically to the
double three-way junction substrates and to localize
sites of protein–DNA interactions. The LTR DNA arms
were lengthened in the substrates used to provide more
DNA sequence on which to assess DNase I cleavage
(indicated by “D” added to the name). The reaction mix-
ture contained 5 mM MgCl2 and 100 mM NaCl, condi-
ions which allow cleavage by DNase I while permitting
ormation of tetrameric complexes of RSV integrase
Coleman et al., 1999).
3H2S-6L-3H2S substrate DNAs were incubated on ice
with full-length RSV integrase and then treated with
DNase I at 37°C (Figs. 8A–8E). Substrates were labeled
either on the U5 LTR arm (Figs. 8A and 8B) or the U3 LTR
arm (Figs. 8C and 8D, diagrammed in 8E). The pattern of
FIG. 6. Cleavage of 2-, 4-, and 6-base bulge substrates. (Lanes 1–6)
Cleavage of 3H2S-6L-3H2S substrate. (Lanes 7–12) Cleavage of 3H4S-
6L-3H4S substrate. (Lanes 13–18) Cleavage of 3H6S-6L-3H6S sub-
strate. A diagram of each substrate is shown above the appropriate
lanes. Substrates were labeled on U5 viral arm and were treated with
RSV IN 49–286 (lanes 1–3, 7–9, and 13–15) or with full-length RSV
integrase (lanes 4–6, 10–12, and 16–18). Reactions were completed in
21the presence of Mn in all lanes except lanes 3, 6, 9, 12, 15, and 18, in
hich Mg21 was used.
310 JOHNSON AND BUSHMANDNase I digestion of the naked DNA substrate is shown
in Fig. 8A, lane 1 and Fig. 8C, lane 1. RSV integrase was
titrated from 40–140 ng per reaction. At 120 ng, 3H2S-6L-
3H2S incubated with RSV integrase showed a pro-
nounced reduction of cleavage at the last 5 bp of the LTR
DNA (Figs. 8A and 8C, lane 6). A band appearing just
above the protection is an integrase cleavage product,
since this band appears in controls containing integrase
but lacking DNase I (data not shown). Some reduction in
cleavage is also apparent in the target region of the
U3-labeled substrate 5 bases downstream of the U5 LTR
end. Some reduction of overall cleavage was also ob-
served, as expected for nonspecific binding. At higher
concentrations of integrase (140 ng and higher), DNase
I cleavage is apparent at all sites in the DNA, indicative
of nonspecific coating of DNA by integrase. Assays of
substrates labeled on the other DNA strand showed little
cleavage by DNase I at the LTR-target junction, preclud-
ing analysis (data not shown).
Quantitation of autoradiograms (0 or 100 ng of RSV
integrase) was carried out by PhosphorImager and Im-
ageQuant software (Figs. 8B and 8D). The gray rectan-
gles indicate regions of protection from DNase I cleav-
FIG. 7. Cleavage of 3H2S-6BL-3H2S, the “bubbled” substrate. Cleav-
age of 3H2S-6L-3H2S is shown in lanes 1–8. Cleavage of 3H2S-6BL-
3H2S is shown in lanes 9–16. A diagram of each substrate is shown
above the appropriate lanes. Substrates were labeled on the U3 arm.
Reactions were carried out for increasing amounts of time in either
Mn21 (lanes 1–4 and 9–12) or Mg21 (lanes 5–8 and 13–16).age at the ends of the LTR DNA. Similar results were
observed when substrates were treated with RSV IN49–286 (data not shown). As a control, DNase protection
experiments were performed by using a linear substrate
which modeled the viral end joined to target DNA (Fig. 9).
No specific protection was observed when RSV inte-
grase was incubated with these substrates. Nonspecific
binding was seen at high concentrations as indicated by
a nonspecific reduction of cleavage across the entire
DNA substrate. Further studies of linear DNAs mimicking
the end of the unintegrated cDNA (not joined to target)
also did not show detectable specific protection (data
not shown). These findings indicate that integrase binds
specifically to the DNA three-way junctions at concen-
trations below those sufficient to coat the substrate.
DISCUSSION
Here, we present oligonucleotide scaffolds that orga-
nize RSV integrase complexes on DNA. Physical assays
of integrase binding to DNA are typically dominated by
nonspecific interactions, probably mimicking target DNA
binding. In an effort to constrain the position of integrase
on DNA, we have devised branched DNA structures
mimicking a reaction intermediate. Normally, the action
of RSV integrase yields an intermediate in which the 39
ends of the viral cDNA are joined to points on the target
spaced 6 bases apart on opposite strands (Fig. 2A). In
the 3H2S-6L-3H2S substrate, the 59 viral end is also
joined to the 39 target end to produce a pair of three-way
DNA junctions with a 2-base bulge (Figs. 2B and 2C). The
DNA strands in the structure are stably base paired
under reaction conditions in vitro, unlike the authentic
integration intermediate (crossbone substrate). The true
integration intermediate DNA, if assembled by annealing
from oligonucleotides, would be held together only by
the 6 bp between the LTR DNA arms (Fig. 2A). Attempts
to study integrase binding to such substrates were not
successful, probably due at least in part to melting of the
linker region (data not shown). We reasoned that stabi-
lizing the DNA strands normally present in the integra-
tion intermediate might allow DNA contacts to constrain
integrase at defined location on DNA.
Assays of integrase-mediated hydrolysis revealed that
integrase could bind productively to the paired DNA
three-way junctions, and that the substrate features mim-
icking the integration intermediate were required for op-
timal catalysis. The mut3H2S-6L-3H2S substrate lacking
the LTR sequences was not cleaved, consistent with
previous findings that mutations in the terminal LTR nu-
cleotides greatly decrease activity on other types of sub-
strates (Bushman and Craigie, 1992; Chow and Brown,
1994a; Gerton and Brown, 1997; Katzman and Katz, 1999;
van den Ent et al., 1994). The 3H2S-11L-3H2S junction,
containing a lengthened linker region between three-
way junctions, also showed disrupted cleavage. Weak
cleavage was seen at the expected location at the end of
the labeled viral DNA arm and also at a site one turn
311DNA SCAFFOLDS FOR INTEGRASE COMPLEX ASSEMBLYFIG. 8. DNase I footprinting of RSV integrase on three-way junction substrates. (A and C) Footprinting on the 3H2S-6L-3H2S substrate. (A)
Footprinting on the U5 labeled substrate (indicated in E with an asterisk). (C) Footprinting on the U3 labeled substrate (indicated in E with a filled
circle). The positions of the target and LTR DNA sequence are shown on the left. The location of protection by integrase is shown by the gray box
on the right. Amounts of protein in ng are indicated. (B and D) Density plots from (A) and (C), respectively, lanes 1 and 5, showing DNase I products
when the 3H2S-6L-3H2S substrate was preincubated with 0 or 100 ng of integrase. The upper plots show DNase I cleavage with 0 ng integrase
(counts per minute indicated on the left), while the lower plots show cleavage in the presence of 100 ng integrase (counts per minute indicated on
the right). The positions of the target and LTR DNA sequence is shown on the bottom. Vertical gray bars show the position of reduced cleavage by
DNase I. The position of substrate cleavage by integrase is indicated by an arrow.
e right)
312 JOHNSON AND BUSHMANaway at the distal three-way junction (Figs. 4D, 5E, and
F). In assays with mut3H2S-11L-3H2S, only cleavage at
FIG. 9. DNase I footprinting of RSV integrase on linear substrates.
substrate. (A) Footprinting on the U5-labeled substrate (indicated in C
with a filled circle). The positions of the target and LTR DNA sequence a
plots from (A) and (D), respectively, lanes 1 and 5, showing DNase I
integrase. The upper plots show DNase I cleavage with 0 ng integrase
in the presence of 100 ng integrase (counts per minute indicated on th
bottom.the aberrant site occurs, indicating that, in this substrate,
LTR sequence is important for normal LTR cleavage, butnot for the ectopic downstream cleavage (Figs. 5G and
5H). These findings emphasize the importance of the
D) Footprinting on linear substrates matched to the 3H2S-6L-3H2S
asterisk). (D) Footprinting on the U3-labeled substrate (indicated in F
n on the left. Amounts of protein in ng are indicated. (B and E) Density
ts when the linear substrates were preincubated with 0 or 100 ng of
per minute indicated on the left), while the lower plots show cleavage
. The positions of the target and LTR DNA sequence are shown on the(A and
with an
re show
produc
(countscorrect DNA scaffold for organizing integration com-
plexes on the paired three-way junctions.
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313DNA SCAFFOLDS FOR INTEGRASE COMPLEX ASSEMBLYThe connection between the viral DNA 59 end and the
target DNA 39 end, while necessary for stable assembly
of the substrate, nevertheless introduces several com-
plications. Increasing the length of the ectopic DNA
bulge increased cleavage in Mg21 (Fig. 6), probably be-
cause longer bulges minimize the constraints on DNA
conformation. Several groups have reported that integra-
tion takes place preferentially on distorted target DNA
(Bor et al., 1995; Pruss et al., 1994; Pryciak et al., 1992a,b;
Pryciak and Varmus, 1992) and that integrase preferen-
tially cleaves frayed DNA sites (Bushman and Craigie,
1992; Katz et al., 1998; Scottoline et al., 1997). Perhaps
distortion due to integrase binding brings the substrates
into active conformations for cleavage, and the longer
the bulge, the less energy required. Base pairs at the
three-way junctions may also be unpaired in the ab-
sence of integrase.
Using DNase I footprinting, we observe specific bind-
ing by integrase to the last 5 bp of the LTR DNA arm (Fig.
8). At higher integrase concentrations, we also observed
nonspecific binding. Models of RSV IN 49–286 binding to
DNA have recently been proposed based on the struc-
ture of the RSV IN 49–286 dimer solved by x-ray crystal-
lography (Yang et al., 2000). In these models, a tetramer
of integrase binds to the integration intermediate. The
catalytic domain binds approximately 5 bp at the tip of
the LTR, while the C-terminal domain binds to more
distal LTR sequences. Crosslinking studies in the HIV
system (Esposito and Craigie, 1998; Heuer and Brown,
1998; Gao et al., in press) also implicate the catalytic
domain in binding this region. Our data indicate protec-
tion of approximately 5–7 bp at the tip of the LTR, sug-
gesting particularly strong binding by the catalytic do-
main to this region.
The ability to assemble integrase with paired three-
way junctions may facilitate ongoing attempts to crystal-
lize integrase bound to DNA, since the paired three-way
junctions promote formation of integrase complexes.
Stable complexes of integrase bound to three-way
junctions may also allow contacts between integrase
amino acids and substrate bases to be studied more
readily.
MATERIALS AND METHODS
Materials
Restriction enzymes, T4 polynucleotide kinase, and
DNase I endonuclease were obtained from commercial
suppliers and used according to the manufacturer’s in-
structions. RSV integrase and RSV IN 49–286 were ob-
tained from the laboratory of Dr. Craig Hyde, and were
used as described below. The RSV IN 49–286 enzyme
used in this study also contains a F199K mutation which
functions to further solubilize the protein.Construction and characterization of substrates
Table 1 lists oligonucleotides used in this study. All
oligonucleotides were synthesized by IDT (Coralville, IA)
and purified by standard means (Sambrook et al., 1989).
When necessary, oligonucleotides were radiolabeled by
treatment with T4 polynucleotide kinase in the presence
of [g-32P]ATP. For annealing of substrates, 1 mM of the
labeled nucleotide and 1.2 mM of unlabeled nucleotides
were mixed in a solution containing 100 mM NaCl and 5
mM MgCl2 in TE buffer (10 mM Tris, pH 8.0, 0.1 mM
DTA). Samples were then incubated at 95°C for 10 min,
nd cooled to 4°C over the course of 60 min.
To assay whether substrates were completely an-
ealed, the 3H2S-6L-3H2S substrate was analyzed by
lectrophoresis on 5% polyacrylamide gels in Tris/Bo-
ate/EDTA buffer or on 8% DNA sequencing-type gels
ollowing cleavage with restriction enzymes (Sambrook
t al., 1989). Reaction products were visualized by auto-
adiography.
ntegrase cleavage assay
Twenty nanograms of RSV integrase or RSV IN 49–286
ere incubated with 0.01 mM of the appropriate sub-
strate in a 10-ml final volume of cleavage buffer [10 mM
ris, pH 8.0, 2 mM b-mercaptoethanol (bME), and 100
mM NaCl] at 4°C for 30 min. Either MgCl2 or MnCl2 at 5
M was then added to the samples which were then
ncubated at 37°C for 0 or 30 min. Reactions were then
topped by the addition of 1 ml 100 mM EDTA and 10 ml
stop buffer (50 mM Tris, pH 8.0, 10 mM EDTA, 0.02%
bromophenol blue, and 0.02% xylene cyanol in form-
amide). Reaction products were then analyzed by PAGE
and autoradiography. Reactions were quantitated with
ImageQuant version 1.2 software.
DNase I footprinting assay
DNase I footprinting assays were performed essen-
tially as described (Galas and Schmitz, 1978). Substrates
used in this study were 3H2S-6L-3H2S(D) and the linear
substrate (Table 1). Full-length RSV integrase or the two
domain RSV IN 49–286 in amounts ranging from 0 to 140
ng were mixed with 0.01 mM of the appropriate substrate
n a final volume of 10 ml of footprinting buffer [10 mM
Tris, pH 8.0, 2 mM bME, 100 mM NaCl, 5 mM MgCl2, and
mg/ml bovine serum albumin (BSA)]. After incubation at
°C for 30 min, 0 or 0.01 unit of DNase I was added in 1
ml of DNase solution (10 mM Tris, pH 8.0, 2 mM bME, 5
M MgCl2) and the sample incubated at 37°C for 10 min.
Reactions were stopped by addition of 10 ml stop buffer
(50 mM Tris, pH 8.0, 10 mM EDTA, 0.02% bromophenol
blue, and 0.02% xylene cyanol in formamide) and ana-
lyzed by electrophoresis on a 6% denaturing gel and
visualized using autoradiography (Sambrook et al., 1989).
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Oligonucleotides Used in this Study
Oligo Sequence Comment
EPJ41 59-GAGCCTCTTCGCAGAAGGCTTCAGTATACCAGTCAGCCGCATGC-39 U5 strand, duplication site and right target of 3H2S-
6L-3H2S
EPJ42 59-GCATGCGGCTGACTGAATGTAGTCTTATGCGAGCGGACAC-39 Right target strand and U3 strand of 3H2S-6L-3H2S
EPJ43 59-GTGTCCGCTCGCATAAGACTACAGTATACGAGTCCACGAGCAGC-39 U3 strand, duplication site, and left target of 3H2S-
6L-3H2S
EPJ44 59-GCTGCTCGTGGACTCAATGAAGCCTTCTGCGAAGAGGCTC-39 Left target strand and U5 strand of 3H2S-6L-3H2S
EPJ45 59-GAGCCTCTTCGCAGAAGGCTTCACGGCGCCAGTCAGCCGCATGC-39 U5 strand duplication site and right target of
crossbone substrate
EPJ46 59-GCATGCGGCTGACTG-39 Right target strand of crossbone
EPJ47 59-AATGTAGTCTTATGCGAGCGGACAC-39 U3 strand of crossbone
EPJ48 59-GTGTCCGCTCGCATAAGACTACAGCGCCGGAGTCCACGAGCAGC-39 U3 strand, duplication site, and left target arm of
crossbone substrate
EPJ49 59-GCTGCTCGTGGACTC-39 Left target strand of crossbone
EPJ50 59-CTCGGAGAAGCGTCTTCCGAAGTAA-39 U5 arm of crossbone
EPJ64 59-GAGCCTCTTCGCAGAAGAGTCTGGTATACCAGTCAGCCGCATGC-39 U5 strand, duplication site and right target of
mutant 3H2S-6L-3H2S
EPJ65 59-GCATGCGGCTGACTGAAGACTAGCTTATGCGAGCGGACAC-39 Right target strand and U3 strand of mutant 3H2S-
6L-3H2S
EPJ66 59-GTGTCCGCTCGCATAAGCTAGTCGTATACGAGTCCACGAGCAGC-39 U3 strand, duplication site, and left target of mutant
3H2S-6L-3H2S
EPJ67 59-GCTGCTCGTGGACTCAACAGACTCTTCTGCGAAGAGGCTC-39 Left target strand and U5 strand of mutant 3H2S-
6L-3H2S
EPJ68 59-GAGCCTCTTCGCAGAAGGCTTCAGTACGTCTTACCAGTCAGCCGCATGC-39 U5 strand, duplication site and right target strand of
3H2S-11L-3H2S
EPJ69 59-GTGTCCGCTCGCATAAGACTACAGTAAGACGTACGAGTCCACGAGCAGC-39 U3 strand, duplication site, and left target strand of
3H2S-11L-3H2S
EPJ115 59-GAGCCTCTTCGCAGAAGAGTCTGGTACGTCTTACCAGTCAGCCGCATGC-39 U5 strand, duplication site and right target strand of
mut3H2S-11L-3H2S
EPJ116 59-GTGTCCGCTCGCATAAGCTAGTCGTAAGACGTACGAGTCCACGAGCAGC-39 U3 strand, duplication site, and left target strand of
mut3H2S-11L-3H2S
EPJ42a 59-GCATGCGGCTGACTGGAATGTAGTCTTATGCGAGCGGACAC-39 Right target strand and U3 strand of 3H2S-6L-3H2S
for Fig. 3C
EPJ43a 59-GTGTCCGCTCGCATAAGACTACATATACGAGTCCACGACAGC-39 U3 strand, duplication site, and left target of 3H2S-
6L-3H2S for Fig. 3C
EPJ420S 59-GCATGCGGCTGACTGTGTAGTCTTATGCGAGCGGACAC-39 Right target strand and U3 strand of 3H-6L-3H
EPJ440S 59-GCTGCTCGTGGACTCTGAAGCCTTCTGCGAAGAGGCTC-39 Left target strand and U5 strand of 3H-6L-3H
EPJ424S 59-GCATGCGGCTGACTGAATTTGTAGTCTTATGCGAGCGGACAC-39 Right target strand and U3 strand of 3H4S-6L-3H4S
EPJ426S 59-GCATGCGGCTGACTGAATTTTTGTAGTCTTATGCGAGCGGACAC-39 Right target strand and U3 strand of 3H6S-6L-3H6S
EPJ444S 59-GCTGCTCGTGGACTCAATTTGAAGCCTTCTGCGAAGAGGCTC-39 Left target strand and U5 strand of 3H4S-6L-3H4S
EPJ446S 59-GCTGCTCGTGGACTCAATTTTTGAAGCCTTCTGCGAAGAGGCTC-39 Left target strand and U5 strand of 3H6S-6L-3H6S
EPJ75 59-CTCAGTCGAAGGACACGAAGTCCTGGACATGATGCTAAGTACTGCACTAC-
GAGCCTCTTCGCAGAAGGCTTCAGTATACCAGTCAGCCGCATGC-39
U5 strand, duplication site and right target of 3H2S-
6L-3H2S(D)
PJ76 59-GCATGCGGCTGACTGAATGTAGTCTTATGCGAGCGGACACCAGTCGACTCTG-
CAGAATGCAGTGGTCTACTTGTGTACCGTACCTGATCG-39
Right target strand and U3 strand of 3H2S-6L-
3H2S(D)
PJ77 59-CGATCAGGTACGGTACACAAGTAGACCACTGCATTCTGCAGAGTCGACTGG-
TGTCCGCTCGCATAAGACTACAGTATACGAGTCCACGAGCAGC-39
U3 strand, duplication site, and left target of 3H2S-
6L-3H2S(D)
PJ78 59-GCTGCTCGTGGACTCAATGAAGCCTTCTGCGAAGAGGCTCGTAGTGCAGTA-
CTTAGCATCATGTCCAGGACTTCGTGTCCTTCGACTGAG-39
Left target strand and U5 strand of 3H2S-6L-
3H2S(D)
PJ79 59-CTCAGTCGAAGGACACGAAGTCCTGGACATGATGCTAAGTACTGCACT-
ACGAGCCTCTTCGCAGAAGAGTCTGGTATACCAGTCAGCCGCATGC-39
U5 strand, duplication site and right target of
mutant 3H2S-6L-3H2S(D)
PJ80 59-GCATGCGGCTGACTGAAGACTAGCTTATGCGAGCGGACACCAGTCGA-
CTCTGCAGAATGCAGTGGTCTACTTGTGTACCGTACCTGATCG-39
Right target strand and U3 strand of mutant 3H2S-
6L-3H2S(D)
PJ81 59-CGATCAGGTACGGTACACAAGTAGACCACTGCATTCTGCAGAGTCG-
ACTGGTGTCCGCTCGCATAAGCTAGTCGTATACGAGTCCACGAGCAGC-39
U3 strand, duplication site, and left target of mutant
3H2S-6L-3H2S(D)
PJ82 59-GCTGCTCGTGGACTCAACAGACTCTTCTGCGAAGAGGCTCGTAGTGC-
AGTACTTAGCATCATGTCCAGGACTTCGTGTCCTTCGACTGAG-39
Left target strand and U5 strand of mutant 3H2S-
6L-3H2S(D)
PJ87 59-GCATGCGGCTGACTGGTATACTGAAGCCTTCTGCGAAGAGGCTCGTA-
GTGCAGTACTTAGCATCATGTCCAGGACTTCGTGTCCTTCGACTGAG-39
When annealed to EPJ75, forms linear substrate
with U5 viral arm
PJ93 59-GCTGCTCGTGGACTCGTATACTGTAGTCTTATGCGAGCGGACACCAG-
TCGACTCTGCAGAATGCAGTGGTCTACTTGTGTACCGTACCTGATCG-39
When annealed to EPJ77, forms linear substrate
with U3 viral arm
PJ125 59-GTGTCCGCTCGCATAAGACTACAACGCGTGAGTCCACGAGCAGC-39 U3 strand, duplication site and left target arm of
3H2S-6BL-3H2S
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